PHP
CARL

Parkman Healthcare Partners’s Carlsmed CARL Stock Holding History

Parkman Healthcare Partners’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.72M Buy
+521,123
New +$6.3M 0.49% 61

Other funds holding CARL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KC
KCM Capital Shawnee, Kansas $622M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parkman Healthcare Partners's CARL Position: Q1 2026 in Review

Parkman Healthcare Partners opened a new position in Carlsmed (CARL) in Q1 2026: 521,123 shares worth $4.72M. The stake represents 0.49% of the portfolio and ranks #61 among its holdings.

66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

  • Parkman Healthcare Partners held 521,123 shares of Carlsmed worth $4.72M as of Q1 2026.
  • Carlsmed was a new Parkman Healthcare Partners position in Q1 2026.
  • Carlsmed made up 0.49% of Parkman Healthcare Partners's portfolio in Q1 2026, its #61 holding.
  • 66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.